NCT02735499View on ClinicalTrials.gov

Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Overactive Bladder
Interventions
DRUG

onabotulinum toxin A

Onabotulinum toxin A is installed into the bladder and EMDA (Electromotive Drug Application) is applied for 30 minutes

Trial Locations (1)

N-3103

Dept of Ob/Gyn, The Hospital of Vestfold, Tønsberg

All Listed Sponsors
collaborator

South-Eastern Norway Regional Health Authority

OTHER

lead

The Hospital of Vestfold

OTHER

NCT02735499 - Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB) | Biotech Hunter | Biotech Hunter